Centivax raises $45M in funding to launch first-ever universal flu vaccine to human trials
Centivax is betting big on ending the flu as we know it. The biotech startup just closed a $45 million Series A round to bring what it says could be the first universal flu vaccine into human trials. The raise [β¦]
The post Centivax raises $45M in funding to launch first-ever universal flu vaccine to human trials first appeared on Tech Startups.